GC
G Bradley Cole
Director

G Bradley Cole insider trades: Castle Biosciences (CSTL) stock sales

Director, Castle Biosciences Last trade Mar 5, 2026 153 Form 4 filings
$211K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
110
Open-market trades
since 2008
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where G reports to the SEC

Open-market buys and sales

110 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 5, 2026CSTL↓ Sell$211K
Feb 19, 2020EXAS↓ Sell10b5-1$2.7M
Jan 16, 2020EXAS↓ Sell10b5-1$903K
Nov 21, 2019EXAS↓ Sell10b5-1$2.3M
Oct 7, 2019GHDX↓ Sell$1.6M
Sep 10, 2019GHDX↓ Sell$3.1M
Aug 12, 2019GHDX↓ Sell$4.4M
Jul 9, 2019GHDX↓ Sell$369K
Jun 11, 2019GHDX↓ Sell$257K
May 14, 2019GHDX↓ Sell$653K
Apr 9, 2019GHDX↓ Sell$1.0M
Mar 12, 2019GHDX↓ Sell$1.1M
Feb 12, 2019GHDX↓ Sell$1.2M
Jan 8, 2019GHDX↓ Sell$1.0M
Dec 11, 2018GHDX↓ Sell$1.1M
Nov 13, 2018GHDX↓ Sell$679K
Oct 10, 2018GHDX↓ Sell$316K
Sep 11, 2018GHDX↓ Sell$320K
Aug 9, 2018GHDX↓ Sell$477K
Mar 13, 2018GHDX↓ Sell$164K
Feb 20, 2018GHDX↓ Sell$164K
Jan 9, 2018GHDX↓ Sell$178K
Dec 12, 2017GHDX↓ Sell$150K
Nov 7, 2017GHDX↓ Sell$157K
Oct 10, 2017GHDX↓ Sell$160K
Sep 12, 2017GHDX↓ Sell$159K
Aug 8, 2017GHDX↓ Sell$153K
Jul 11, 2017GHDX↓ Sell$163K
Jun 13, 2017GHDX↓ Sell$158K
Mar 8, 2017GHDX↓ Sell$180K
Feb 15, 2017GHDX↓ Sell$145K
Jan 10, 2017GHDX↓ Sell$146K
Dec 6, 2016GHDX↓ Sell$153K
Nov 8, 2016GHDX↓ Sell$148K
Oct 10, 2016GHDX↓ Sell$254K
Sep 6, 2016GHDX↓ Sell$110K
Aug 11, 2016GHDX↓ Sell$144K
Jul 6, 2016GHDX↓ Sell$133K
Jun 9, 2016GHDX↓ Sell$133K
May 16, 2016GHDX↓ Sell$138K
Jan 12, 2016GHDX↓ Sell$127K
Dec 8, 2015GHDX↓ Sell$117K
Nov 10, 2015GHDX↓ Sell$104K
Sep 9, 2015GHDX↓ Sell$245K
Jul 7, 2015GHDX↓ Sell$110K
Jun 9, 2015GHDX↓ Sell$105K
May 12, 2015GHDX↓ Sell$110K
Apr 7, 2015GHDX↓ Sell$122K
Mar 10, 2015GHDX↓ Sell$127K
Feb 10, 2015GHDX↓ Sell$125K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CSTL insiders

Open-market trades in the last 12 months

About G Bradley Cole's insider trades

G Bradley Cole is a director at Castle Biosciences (CSTL). Since Feb 19, 2008, G has reported no open-market purchases and 110 sales worth $33.4M on SEC Form 4. In the last 12 months: 1 sale ($211K).

6 sales (20% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (117 filings), grants and awards (31 filings), shares withheld for taxes (8 filings), gifts (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CSTL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.